Tuesday 26 November 2013

Central and Eastern Europe Pharmaceutical Market Forecasts to 2018: Industrial Report



New Market Research Report Added in MarketResearchReports.Biz Reports Database: Central and Eastern Europe Pharmaceutical Market Forecasts to 2018

The global pharmaceutical market is forecast to be worth over US$1,250 billion by 2018 - but where are the key opportunities? And how does Central and Eastern Europe fit into this global outlook?

This analysis report, Central and Eastern Europe Pharmaceutical Market Forecasts to 2018 (published November 2013), is an essential resource for business forecasters, marketing planners, the investment community and anyone looking to understand the future outlook for the challenging pharmaceutical industry within this region.


You will benefit from:

  • Growth forecasts to 2018 for 11 key country markets
  • Comparative data on a regional basis
  • Rankings by indicators allowing ‘at a glance’ benchmarking of countries
  • Detailed information on each market
  • PDF delivery with Excel data pack
  • Easily exported data to enhance your business plans

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/179635

Each individual country market provides detail and forecasts at a national level, with focus for key pharmaceutical product areas.

This report will show you growth forecasts to 2018 for 11 key country markets and across Central and Eastern Europe - allowing you to compare and assess the opportunities and challenges that will arise for your business. With an in-depth look at this regional market, you can better assess the region (and each country’s future potential and reflect this with strategic planning and investment decisions.


Latest Reports:

Americas Pharmaceutical Market Forecasts to 2018: http://www.marketresearchreports.biz/analysis-details/asia-pharmaceutical-market-forecasts-to-2018              

The global pharmaceutical market is forecast to be worth over US$1,250 billion by 2018 - but where are the key opportunities? And how does Asia fit into this global outlook?

This analysis report, Asia Pharmaceutical Market Forecasts to 2018 (published November 2013), is an essential resource for business forecasters, marketing planners, the investment community and anyone looking to understand the future outlook for the challenging pharmaceutical industry within this region.

You will benefit from:

  • Growth forecasts to 2018 for 18 key country markets
  • Comparative data on a regional basis
  • Rankings by indicators allowing ‘at a glance’ benchmarking of countries
  • Detailed information on each market
  • PDF delivery with Excel data pack
  • Easily exported data to enhance your business plans

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/179634

Each individual country market provides detail and forecasts at a national level, with focus for key pharmaceutical product areas.

This report will show you growth forecasts to 2018 for 18 key country markets and across Asia - allowing you to compare and assess the opportunities and challenges that will arise for your business. With an in-depth look at this regional market, you can better assess the region (and each country’s future potential and reflect this with strategic planning and investment decisions.


Asia Pharmaceutical Market Forecasts to 2018: http://www.marketresearchreports.biz/analysis-details/asia-pharmaceutical-market-forecasts-to-2018                

The global pharmaceutical market is forecast to be worth over US$1,250 billion by 2018 - but where are the key opportunities? And how does Asia fit into this global outlook?

This analysis report, Asia Pharmaceutical Market Forecasts to 2018 (published November 2013), is an essential resource for business forecasters, marketing planners, the investment community and anyone looking to understand the future outlook for the challenging pharmaceutical industry within this region.

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/179634

You will benefit from:

  • Growth forecasts to 2018 for 18 key country markets
  • Comparative data on a regional basis
  • Rankings by indicators allowing ‘at a glance’ benchmarking of countries
  • Detailed information on each market
  • PDF delivery with Excel data pack
  • Easily exported data to enhance your business plans

Each individual country market provides detail and forecasts at a national level, with focus for key pharmaceutical product areas.

This report will show you growth forecasts to 2018 for 18 key country markets and across Asia - allowing you to compare and assess the opportunities and challenges that will arise for your business. With an in-depth look at this regional market, you can better assess the region (and each country’s future potential and reflect this with strategic planning and investment decisions.

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948

Monday 25 November 2013

Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use

New Market Research Report Added in MarketResearchReports.Biz Reports Database: Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use
  
, "Cardiovascular Diseases Therapeutics Market in Asia-Pacific to 2019 - Promising Pipeline Drugs to Offset Revenue Decline from Generic Erosion and Off-Label Use", which provides insights into three cardiovascular therapeutic indications in in Asia-Pacific (APAC) markets of India, China, Japan and Australia. The report provides an in-depth analysis of the cardiovascular therapeutic indications, namely heart failure, myocardial infarction (MI), acute coronary syndrome (ACS). The report provides an estimation of market size for 2012, along with market forecast until 2019. It also covers disease epidemiology, treatment algorithms, treatment patterns, in-depth analysis of the pipeline, and deal analysis for these three cardiovascular indications.


Scope

  • Disease overview and treatment usage patterns
  • Market size and forecast for heart failure, MI and ACS in APAC market from 2012 to 2019
  • Major marketed products for the indications types covered
  • In-depth pipeline analysis for heart failure, MI and ACS
  • Key drivers and restraints that have had and are expected to have a significant impact upon the market
  • Key licensing and co-development agreements in the cardiovascular market

Click Here To Download Detail Report: http://www.marketresearchreports.biz/sample/sample/179627

Reasons to Buy

The report will enhance your decision-making capability by allowing you to:

  • Align your product portfolio to the markets with high growth potential
  • Develop market entry and expansion strategies by identifying the potential regions and therapeutic segments poised for strong growth
  • Devise a more effectively tailored country strategy through the understanding of key drivers and barriers in the cardiovascular market
  • Develop key strategic initiatives based upon an understanding of key focus areas and leading companies
  • Accelerate and strengthen your market position by identifying key companies for mergers, acquisitions and strategic partnerships

Table of Contents

1 Table of Contents
1.1 List of Tables
1.2 List of Figures

2 Introduction

3 Therapeutic Landscape
3.1 Heart Failure
3.1.1 Symptoms
3.1.2 Etiology
3.1.3 Pathophysiology
3.1.4 Co-morbidities and Complications
3.1.5 Diagnosis
3.1.6 Classification
3.1.7 Prognosis and Disease Staging
3.1.8 Treatment Options
3.2 Myocardial Infarction
3.2.1 Symptoms
3.2.2 Etiology
3.2.3 Pathophysiology
3.2.4 Co-morbidities and Complications
3.2.5 Diagnosis
3.2.6 Classification
3.2.7 Treatment Options
3.3 Acute Coronary Syndrome
3.3.1 Symptoms
3.3.2 Etiology
3.3.3 Pathophysiology
3.3.4 Diagnosis
3.3.5 Treatment Options

To Buy The Copy of This Report Visit: http://www.marketresearchreports.biz/analysis/179627

4 Marketed Products
4.1 Heart Failure
4.2 Myocardial Infarction
4.3 Acute Coronary Syndrome
4.4 Key Marketed Products
4.4.1 Arixtra (GlaxoSmithKline plc)
4.4.2 Brilinta (AstraZeneca plc)
4.4.3 Crestor (AstraZeneca plc)
4.4.4 Diovan (valsartan) and Diovan HCT/Co-Diovan (valsartan and hydrochlorothiazide)
4.4.5 Atacand (candesartan)
4.4.6 Lipitor (Atorvastatin Tablets)
4.4.7 Clopidogrel bisulfate
4.4.8 Angiomax (bivaluridin)
4.4.9 Lovenox (enoxaparin sodium injection)
4.4.10 Norvasc (amlodipine)
4.4.11 Coreg
4.4.12 Ivabradine (Les Laboratoires Servier SAS)
4.4.13 Toprol-XL

5 Pipeline Analysis
5.1 Heart Failure Pipeline
5.1.1 Overall Pipeline
5.1.2 Pipeline Analysis by Molecule Type
5.1.3 Pipeline Analysis by Mechanism of Action
5.2 Myocardial Infarction Pipeline
5.2.1 Overall Pipeline
5.2.2 Pipeline Analysis by Molecule Type
5.2.3 Pipeline Analysis by Mechanism of Action

About Us

MarketResearchReports.Biz is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
Blog: http://marketresearchreportsbiz.blogspot.in/